ROLE OF HERBAL MEDICINES IN VITILIGO TREATMENT - CURRENT STATUS AND FUTURE PERSPECTIVES

  • Radhakrishnan Narayanaswamy Bio-Incubator and Lab, Vel Tech Technology Incubator, Vel Tech Rangarajan Dr. Sagunthala R & D Institute of Science and Technology, 400 Feet Outer Ring Road, Avadi, Chennai – 600 062, Tamil Nadu, India.
  • Intan Safinar Ismail Laboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM, Serdang, Selangor, Malaysia.

Abstract

Vitiligo is a depigmentation disorder with complex causes. Nonetheless, recent progress has been made to unravel the pathophysiology of vitiligo. In this review, we provide an overview of the currently known herbal medicine for vitiligo treatment and also highlighted the herbs that have been used in clinical trials. In view of traditional uses, herbs such as Ammi visnaga L., Angelica sinensis, Eclipta alba L, Ginkgo biloba, Picrorhiza kurroa Royle Ex Benth, and Psoralea corylifolia L, have been highlighted. Enormous efforts in vitiligo drug discovery are currently needed. Interleukin-17 inhibition, tumor necrosis factor-alpha inhibition, heat shock protein-70i (HSP70i) inhibition, keratinocyte turnover modulators, and regulatory T cells (Tregs) modulators have been discussed as promising new targets for vitiligo drug development. Thus, we strongly believe that this review may be useful for rationalize new herbal drug for vitiligo treatment.

Keywords: Vitiligo, Melanocyte, Ammi visnaga, Psoralea corylifolia, Regulatory T cells (Tregs) modulators.

References

1. Abu Tahir M, Pramod K, Ansari SH, Ali J. Current remedies for vitiligo. Autoimmun Rev 2010;9:516-20.
2. Ansari FZ, Alam S, Jain P, Akhter S, Ansari MZ. Vitiligo and its herbal treatment. Pharm Rev 2008;12:137-9.
3. Adauwiyah J, Suraiya HH. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients. Med J Malaysia 2010;65:299-1.
4. Wong SM, Baba R. Quality of life among Malaysian patients with vitiligo. Int J Dermatol 2012;51:158-61.
5. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: Prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002;16:573-8.
6. Nordlund JJ, Lerner AB. Vitiligo: It is important. Arch Dermatol 1982;118:5-8.
7. Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R. Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol 2006;44:526-39.
8. Costin GE, Hearing VJ. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J 2007;21:976-94.
9. Speeckaert R, Speeckaert MM, van Geel N. Why treatments do (n’t) work in vitiligo: An autoinflammatory perspective. Autoimmun Rev 2014;14:332-40.
10. Soni P, Patidar R, Soni V, Soni S. A Review on traditional and alteranative treatment for skin disease vitiligo”. Int J Pharm Biol Arch 2010;1:220-7.
11. Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med 2014;6:223ra23.
12. Lindsay HC. Leukoderma—its treatment. Cal West Med 1932;37:36 41.
13. El Mofty AM. A preliminary clinical report on the treatment of leucoderma with Ammi majus Linn. J Egypt Medl Assoc 1948;31:651 65.
14. Szczurko O, Boon HS. A systematic review of natural health product treatment for vitiligo. BMC Dermatol 2008;8:2.
15. Wat CK, Johns T, Towers GN. Phototoxic and antibiotic activities of plants of the Asteraceae used in folk medicine. J Ethnopharmacol 1980;2:279-90.
16. Bark KM, Heo EP, Han KD, Kim MB, Lee ST, Gil EM, et al. Evaluation of the phototoxic potential of plants used in oriental medicine. J Ethnopharmacol 2010;127:11-8.
17. Srivastava RK. Vitiligo (leukoderma) Ayurvedic Treatment-2011. Available from: http://www.ayurveda-foryou.com/treat/leucoderma. html.
18. Yoon J, Kim TH, Sun YW. Complementary and Alternative Medicine for Vitiligo: Vitiligo-Management and Therapy. In: Park KK, Murase JE, editors. Croatia, Europe: InTech Publisher; 2011.
19. Zhang X, Feng J, Mu K, Ma H, Niu X, Liu C, et al. Effects of single herbal drugs on adhesion and migration of melanocytes. J Tradit Chin Med 2005;25:219-21.
20. Babitha S, Shin JH, Nguyen DH, Park SJ, Reyes GA, Caburian A, et al. A stimulatory effect of Cassia occidentalis on melanoblast differentiation and migration. Arch Dermatol Res 2011;303:211-6.
21. Li HW, Zhu WY, Xia MY. Melanogenic effects of ethanol extracts obtained from 5 traditional Chinese medicines on shape and properties of melanocytes from skin of brownish guinea pigs. J Clin Dermatol 2001;30:69-71.
22. Mou KH, Zhang XQ, Yu B, Zhang ZL, Feng J. Promoting of melanocyte adhesion and migration by Malytea Scurfpea fruit in vitro. Methods Find Exp Clin Pharmacol 2004;26:167-70.
23. Lin Z, Hoult JR, Bennett DC, Raman A. Stimulation of mouse melanocyte proliferation by Piper nigrum fruit extract and its main alkaloid, piperine. Planta Med 1999;65:600-3.
24. Chiang SH, Chen YS, Hung MS, Lee SM, Lin CC. The enhancement effect of Salvia miltiorrhiza on melanin production of B16F10 melanoma cells. J Med Plant Res 2012;6:4338-42.
25. Zhuang SR, Chiu HF, Chen SL, Tsai JH, Lee MY, Lee HS, et al. Effects of a Chinese medical herbs complex on cellular immunity and toxicity-related conditions of breast cancer patients. Br J Nutr 2012;107:712-8.
26. Dhasarathan P, Gomathi R, Theriappan P, Paulsi S. Immunomodulatory activity of alcoholic extract of different fruits in mice. J Appl Sci Res 2010;6:1056-9.
27. Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 2003;28:285-7.
28. Paarakh PM. Nigella sativa Linn.–a comprehensive review. Indian J Nat Prod Resour 2010;1:409-29.
29. Khushboo PS, Jadhav VM, Kadam VJ, Sathe NS. Psoralea corylifolia Linn.—Kushtanashini”. Pharmacogn Rev 2010;4:69-76.
30. de la Cruz J, Lee WS, Hwang SG. Immunomodulatory effect of Cnidium officinale Makino extract in murine peritoneal macrophages and splenocytes. World J Pharm Pharm Sci 2013;2:867-77.
31. Jayathirtha MG, Mishra SH. Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. Phytomedicine 2004;11:361-5.
32. Karthikumar S, Jegatheesan K, Thangaraja A, Banupriya K, Dhivya T, Malarvizhi JM. Immunomodulatory activity of Eclipta prostrata in SRBC immunized mice. J Pharmacog Phytother 2011;3:52-5.
33. Deng Y, Yang L. Effect of Angelica sinensis (Oliv.) on melanocytic proliferation, melanin synthesis and tyrosinase activity in vitro. Di Yi Jun Yi Da Xue Xue Bao 2003;23:239-41.
34. Ong CY, Ling SK, Ali RM, Chee CF, Samah ZA, Ho AS, et al. Systematic analysis of in vitro photo-cytotoxic activity in extracts from terrestrial plants in Peninsula Malaysia for photodynamic therapy. J Photochem Photobiol B Biol 2009;96:216-22.
35. Radhakrishnan N, Intan SI. Cosmetic potential of Southeast Asian herbs: An overview. Phytochemy Rev 2015;14:419-28.
36. Huma A, Rizwani GH, Usman M, Ishaque S, Ansari SA, Anwer S. Drug development of herbomineral capsule (ALG-06) used for hypopigmentation specially in vitiligo. Pak J Pharm Sci 2014;27:1451 7.
37. Ediriweera ER, Kalawana OT, Karunarathna N, Nanayakkara NG. Clinical study on efficacy of the traditional Sri Lankan oil’ the Kakodumbaradi Taila’ with selected ayurvedic preparations on shvitra (vitiligo). AYU 2009;30:225-31.
38. Available from: http://www.jrksiddha.com/products/tolenorm_oil.htm.
39. Madan R, Asrani F. In: Norman RA, Sheneflt PD, Rupani RN, editors. Integrative Management of Vitiligo: Integrative Dermatology. UK: Oxford University Press, Weil Integrative Medicine Library Series; 2014.
40. Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: An open label pilot clinical trial. BMC Complementary Altern Med 2011;11:21.
41. Chakraborty T, Bose A, Barik S, Goswami KK, Banerjee S, Goswami S, et al. Neem leaf glycoprotein inhibits CD4+ CD25+ Foxp3+ Tregs to restrict murine tumor growth. Immunotherapy 2011;3:949-69.
42. Zhu Y, Wang S, Lin F, Li Q, Xu A. The therapeutic effects of EGCG on vitiligo. Fitoterapia 2014;99:243-51.
43. Kim HJ, Park WS, Koh HJ, Min DJ, Park NH, Park PJ, et al. Composition for Preventing or Treating Poliosis or Vitiligo Comprising a Pueraria Genus plant Extract or Puerarin. US Patent No. 2014:8901088.
44. Ferreira EQ. Pharmaceutical Composition on the Basis of Stachytarpheta sp., a Process for Obtaining the same and its use for Treating Vitiligo. US Patent No. 2013:20130287868.
45. Paleo RA, Rojas UJ. Natural Product in Cream with Anti-vitiligo Therapeutic Properties. EP No. 2007:1747786.
46. Msika P, Saunois A, Leclere-Bienfait S, Baudoin C. Vigna unguiculata Seed Extract and Compositions Containing Same. EP No. 2014:2506724.
47. Vidal K, Blum-Sperisen S, Philippe D, Ballevre O, Bucheli P, Wang J. Wolfberries and Skin Inflammation. EP No. 2010:2200624.
48. Liotta S. Topical Preparation Containing ngf for Inducing Skin Pigmentation and for the Treatment of Cutaneous Dyschromias and Vitiligo. US Patent No. 2014:0242007.
49. Shang J, Liao S, Jin Y, Tian X, Zhao G, Zhou J, et al. Application of Fluoxetine to Treatment of Depigmentation Diseases. US Patent No. 2015:0065580.
50. Bacus S. Compositions and Methods for Treatment of Vitiligo. US Patent No. 2015:8946256.
51. Hantash BM, Ubeid AA. Peptide Tyrosinase Activators. US Patent No. 2015:0152139.
52. Bacus S, Moran D. Compositions and Methods for Treatment of vitiligo. US Patent No. 2015:0202187.
53. Magilavy D. Treatment for Vitiligo. US Patent No. 2015:9034881.
54. Wilson DT. Compositions and Methods for Treating Vitiligo. WO No. 2015:084875.
55. Kim EK, Shin JH, Babitha S, Reyes G, Adeltrudes C. A Pharmaceutical Composition Comprising Extract of Cassia occidentalis as an Active Ingredient for Treatment of Vitiligo. KR No. 2011:0008609.
56. Kim EK, Shin JH, Babitha S, Reyes G, Adeltrudes C. A Pharmaceutical Composition Comprising Extract of Cassia occidentalis as an Active Ingredient for Treatment of Vitiligo. KR No. 2011:0008609.
57. Ku CS, Kim MJ, Jang DI. Composition Comprising the Liquiritigenin for Prevention and Treatment of Vitiligo. KR No. 2015:0118670.
58. Bhadra R, Pal P, Roy R, Dutta AK. Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo. US Patent No. 1997:5690966.
59. Peicai S. Medicinal Composition for Treating Childhood Vitiligo. CN No. 2016:105343195.
60. Pandey RS. Discovery of novel ayurvedic formulation for the treatment of vitiligo. Asian J Med Sci 2015;6:132-3.
61. Jain A, Sinha P, Jain A, Vavilala S. Estimation of flavonoid content, polyphenolic content and antioxidant potential of different parts of Abrus precatorius (L). Int J Pharm Pharm Sci 2015;7:157-63.
62. Adham AN. Simultaneous estimation of caffeic and chlorogenic acid content in Ammi majus seed by TLC and HPLC. Int J Pharm Pharm Sci 2015;7:263-7.
63. Katiyar D, Singh V, Ali M. Isolation, characterization and prediction of biological activity of two new fatty esters and a phenol from the heartwood of Pterocarpus marsupium Roxb. Int J Pharm Pharm Sci 2017;9:117-22.
64. Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med 2013;5:174ra28.
Statistics
1726 Views | 560 Downloads
Citatons
How to Cite
Narayanaswamy, R., and I. S. Ismail. “ROLE OF HERBAL MEDICINES IN VITILIGO TREATMENT - CURRENT STATUS AND FUTURE PERSPECTIVES”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 9, Sept. 2018, pp. 19-23, doi:10.22159/ajpcr.2018.v11i9.26830.
Section
Review Article(s)